Clinical efficacy and safety of 4-hexyl-1,3-phenylenediol for improving skin hyperpigmentation

Archives of Dermatological Research

Volumn 306, Issue 5, 2014, Pages 455-465

  Won, Yen Kim ^a   Loy, Chong Jin ^a   Randhawa, Manpreet ^a   Southall, Michael D ^a  

^a JOHNSON AND JOHNSON   (United States)

Author keywords

4 hexyl 1,3 phenylenediol; Melanogenesis; Skin hyperpigmentation; Tyrosinase

Indexed keywords

HEXYLRESORCINOL; MONOPHENOL MONOOXYGENASE; 4-HEXYL-1,3-PHENYLENEDIOL; LACTATE DEHYDROGENASE; MELANIN; RESORCINOL DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERABILITY; ENZYME INHIBITION; EPIDERMIS; FEMALE; HUMAN; HUMAN CELL; HYPERPIGMENTATION; IN VITRO STUDY; LOTION; MAJOR CLINICAL STUDY; MELANOCYTE; MELANOGENESIS; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SKIN PIGMENTATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CLINICAL TRIAL; CYTOLOGY; DRUG EFFECTS; EXPERIMENTAL MELANOMA; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; METABOLISM; TREATMENT OUTCOME; TUMOR CELL LINE;

ADULT; ANIMALS; CELL LINE, TUMOR; FEMALE; HUMANS; HYPERPIGMENTATION; L-LACTATE DEHYDROGENASE; MELANINS; MELANOCYTES; MELANOMA, EXPERIMENTAL; MICE; MONOPHENOL MONOOXYGENASE; RESORCINOLS; SKIN PHYSIOLOGICAL PHENOMENA; SKIN PIGMENTATION; TREATMENT OUTCOME;

EID: 84903761747     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-014-1439-9     Document Type: Article

References (55)

1. Amer M, Metwalli M (2000) Topical liquiritin improves melasma. Int J Dermatol 39:299-301 (Pubitemid 30260812)
2. Briganti S, Camera E, Picardo M (2003) Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 16:101-110 (Pubitemid 36596955)
3. Buta JG, Moline HE, Spaulding DW, Wang CY (1999) Extending storage life of fresh-cut apples using natural products and their derivatives. J Agric Food Chem 47:1-6 (Pubitemid 29179613)
4. Chen QX, Ke LN, Song KK, Huang H, Liu XD (2004) Inhibitory effects of hexylresorcinol and dodecylresorcinol on mushroom (Agaricus bisporus) tyrosinase. Protein J 23:135-141 (Pubitemid 41399336)
5. Choi S, Park YI, Lee SK, Kim JE, Chung MH, Park YI (2002) Aloesin inhibits hyperpigmentation induced by UV radiation. Clin Exp Dermatol 27:513-515 (Pubitemid 35278947)
6. De Caprio AP (1999) The toxicology of hydroquinone-relevance to occupational and environmental exposure. Crit Rev Toxicol 29:283-330
7. Fantasia J, Tucker-Samaras S, Saclier S (2011) A synthetic NF-κB inhibitor has significant anti-aging benefits on photodamaged facial skin. J Am Acad Dermatol 64(suppl 1):AB22
8. Findlay GH, Morrison JGL, Simson IW (1975) Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol 93:613-622 (Pubitemid 8013178)
9. Frankos VH, Schmitt DF, Haws LC, McEvily AJ, Iyengar R, Miller SA, Munro IC, Clydesdale FM, Forbes AL, Sauer RM (1991) Generally recognized as safe (GRAS) evaluation of 4-hexylresorcinol for use as a processing aid for prevention of melanosis in shrimp. Regul Toxicol Pharmacol 14:202-212
10. Haddad AL, Matos LF, Brunstein F, Ferreira LM, Silva A, Costa D Jr (2003) A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma. Int J Dermatol 42:153-156 (Pubitemid 41709845)
11. Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miayamoto K, Greatens A, Hillebrand GG, Bissett DL, Boissy RE (2002) The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol 147:20-31 (Pubitemid 34779433)
12. Hoshaw RA, Zimmerman KG, Menter A (1985) Ochronosis-like pigmentation from hydroquinone bleaching creams in American Blacks. Arch Dermatol 121:105-108 (Pubitemid 16225032)
13. Ito S (2003) The IFPCS presidential lecture: a chemist's view of melanogenesis. Pigment Cell Res 16:230-236
14. Ito S, Wakamatsu K (2006) Chemistry of Melanins. In: The pigmentary system. Physiology and pathophysiology, 2nd edn. Blackwell Publishing, Oxford, pp 282-310
15. Jahaveri SM, Handa S, Kaur I, Kumar B (2001) Safety and efficacy of glycolic acid facial peel in Indian women with melasma. Int J Dermatol 40:354-357 (Pubitemid 32851116)
16. Jiménez-Cervantes C, Solano F, Kobayashi T, Urabe K, Hearing VJ, Lozano JA, García-Borrón JC (1994) A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). J Biol Chem 269:17993-18001
17. Jones K, Hughes J, Hong M, Jia Q, Orndorff S (2002) Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res 15:335-340
18. Kakita LS, Lowe NJ (1998) Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther 20:960-970 (Pubitemid 28535731)
19. Kang WH, Chun SC, Lee S (1998) Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. J Dermatol 25:587-596 (Pubitemid 28484052)
20. Kasraee B, Handjani F, Parhizgar A, Omrani GR, Fallahi MR, Amini M, Nikbakhsh M, Tran C, Hügin A, Sorg O, Saurat JH (2005) Topical methimazole as a new treatment for postinflammatory hyperpigmentation: report of the first case. Dermatology 211:360-362 (Pubitemid 41642113)
21. Khatib S, Nerya O, Musa R, Shmuel M, Tamir S, Vaya J (2005) Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety. Bioorg Med Chem 13:433-441 (Pubitemid 39642925)
22. Kim YJ, Chung JE, Kurisawa M, Uyama H, Kobayashi S (2004) New tyrosinase inhibitors, (+)-catechin-aldehyde polycondensates. Biomacromolecules 5:474-479 (Pubitemid 38404483)
23. Kim DS, Kim SY, Park SH, Choi YG, Kwon SB, Kim MK, Na JI, Youn SW, Park KC (2005) Inhibitory effects of 4-n-butylresorcinol on tyrosinase activity and melanin synthesis. Biol Pharm Bull 28:2216-2219
24. Kobayashi T, Urabe K, Winder AJ, Jiménez-Cervantes C, Imokawa G, Brewington T, Solano F, García-Borrón JC, Hearing VJ (1994) Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 13:5818-5825
25. Kolbe L, Mann T, Gerwat W, Batzer J, Ahlheit S, Scherner C, Wenck H, Stab F (2013) 4-n-butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation. J Eur Acad Dermatol Venereol 27(Suppl 1):19-23
26. Kondo T, Hearing VJ (2011) Update on the regulation of mammalian melanocyte function and skin pigmentation. Expert Rev Dermatol 6:97-108
27. Kraal JH, Hussain AA, Gregorio SB, Akaho E (1979) Exposure time and the effect of hexylresorcinol on bacterial aggregates. J Dent Res 58:2125-2131 (Pubitemid 10175338)
28. Land EJ, Ito S, Wakamatsu K, Riley PA (2003) Rate constants for the first two chemical steps of eumelanogenesis. Pigment Cell Res 16:487-493 (Pubitemid 37093025)
29. McNally D, Shephard A, Field E (2012) Randomised, double-blind, placebo-controlled study of a single dose of an amylmetacresol/2,4- dichlorobenzyl alcohol plus lidocaine lozenge or a hexylresorcinol lozenge for the treatment of acute sore throat due to upper respiratory tract infection. J Pharm Pharm Sci 15:281-294
30. Moon KY, Ahn KS, Lee J, Kim YS (2001) Kojic acid, a potential inhibitor of NF-kappa B activation in transfectant human HaCaT and SCC13 cells. Arch Pharm Res 24:307-311 (Pubitemid 33703578)
31. Murphy EJ, Roberts E, Horrocks LA (1993) Aluminum silicate toxicity in cell cultures. Neuroscience 55:597-605 (Pubitemid 23211370)
32. Napolitano A, Memoli S, Crescenzi O, Prota G (1996) Oxidative polymerization of the pheomelanin precursor 5-Hydroxy-1,4-benzothiazinylalanine: a new hint to the pigment structure. J Org Chem 61:598-604 (Pubitemid 26069734)
33. Napolitano A, Di Donato P, Prota G (2000) New regulatory mechanisms in the biosynthesis of pheomelanins: rearrangement vs. redox exchange reaction routes of a transient 2H-1,4-benzothiazine-o-quinonimine intermediate. Biochim Biophys Acta 1475:47-54 (Pubitemid 30259238)
34. Olivares C, Jiménez-Cervantes C, Lozano JA, Solano F, García-Borrón JC (2001) The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase. Biochem J 354:131-139 (Pubitemid 32183453)
35. Paine C, Sharlow E, Liebel F, Eisinger M, Shapiro S, Seiberg M (2001) An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol 116:587-595 (Pubitemid 32299849)
36. Palumbo A, Solano F, Misuraca G, Aroca P, Garcia Borron JC, Lozano JA, Prota G (1991) Comparative action of dopachrome tautomerase and metal ions on the rearrangement of dopachrome. Biochim Biophys Acta 1115:1-5
37. Park HY, Kosmadaki M, Yaar M, Gilchrest BA (2009) Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci 66:1493-1506
38. Penney KB, Smith CJ, Allen JC (1984) Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol 82:308-310 (Pubitemid 14131450)
39. Piao LZ, Park HR, Park YK, Lee SK, Park JH, Park MK (2002) Mushroom tyrosinase inhibition activity of some chromones. Chem Pharm Bull 50:309-311 (Pubitemid 41685629)
40. Rabbani GH, Gilman RH, Kabir I, Mondel G (1985) The treatment of Fasciolopsis buski infection in children: a comparison of thiabendazole, mebendazole, levamisole, pyrantel pamoate, hexylresorcinol and tetrachloroethylene. Trans R Soc Trop Med Hyg 79:513-515 (Pubitemid 15013289)
41. Roure R, Nollent V, Bertin C, Perron-Eymery S (2011) A double-blind, placebo-controlled study demonstrated the anti-aging efficacy of a NF-κB inhibitor and ascorbic acid-2 glucoside containing product. J Am Acad Dermatol 64(suppl 1):AB22
42. Sanchez JL, Vazquez M (1982) A hydroquinone solution in the treatment of melasma. Int J Dermatol 21:55-58 (Pubitemid 12171818)
43. Shimizu K, Kondo R, Sakai K (2000) Inhibition of tyrosinase by flavonoids, stilbenes and related 4-substituted resorcinols: structure-activity investigations. Planta Med 66:11-15 (Pubitemid 30097272)
44. Shimogaki H, Tanaka Y, Tamai H, Masuda M (2000) In vitro and in vivo evaluation of ellagic acid on melanogenesis inhibition. Int J Cosmetic Sci 22:291-303 (Pubitemid 30639205)
45. Simon JD, Peles D, Wakamatsu K, Ito S (2009) Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function. Pigment Cell Melanoma Res 22:563-579
46. Slominski A, Tobin DJ, Shibahara S, Wortsman J (2004) Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev 84:1155-1228 (Pubitemid 39287950)
47. Slominski A, Zmijewski MA, Pawelek J (2012) L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res 25:14-27
48. Smith CJ, O'Hare KB, Alle JC (1988) Selective cytotoxicity of hydroquinone for melanocyte-derived cells is mediated by tyrosinase activity but independent of melanin content. Pigment Cell Res 1:386-389
49. Smith W (1999) The effects of topical L (+) lactic acid and ascorbic acid on skin whitening. Int J Cosmetic Sci 21:33-40
50. Solano F, Briganti S, Picardo M, Ghanem G (2006) Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 19:550-571 (Pubitemid 44674109)
51. Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ (1992) A second tyrosinase-related protein, TRP-2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 11:519-526
52. Ubeid A, Do S, Nye C, Hantash BM (2012) Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides. Biochim Biophys Acta 1820:1481-1489
53. Urabe K, Nakayama J, Hori Y (1998) Mixed epidermal and dermal hypermelanoses. In: The pigmentary system. Physiology and pathophysiology. Oxford University Press, New York, pp 909-11
54. Wakamatsu K, Ohtara K, Ito S (2009) Chemical analysis of late stages of pheomelanogenesis: conversion of dihydrobenzothiazine to a benzothiazole structure. Pigment Cell Melanoma Res 22:474-486
55. Yen GC, Duh PD, Lin CW (2003) Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic Res 37:509-514